Prophylaxis of Postoperative Nausea & Vomiting After Cardiac Surgery

Status Completed

Clinical Trial Summary

To investigate the role of postoperative nausea and vomiting risk factors assessment after cardiac surgery. We designed a randomized controlled study comparing standard care (no risk factor assessment and no intervention) with prophylaxis of postoperative nausea and vomiting after cardiac surgery in high risk patients. Prophylaxis of postoperative nausea and vomiting by betamethasone (4mg) and/or droperidol (0.625mg) immediately after cardiac surgery, depending on risk factors (if risk score is over 2) in the intervention arm.

Clinical Trial Description

Patients planned to undergo cardiac surgery were screened for inclusion. Inclusion criteria are as follow: Non emergent cardiac surgery; Age > 18 years; Affiliation to French Social Security; Approval of participation to the study; at the exclusion of: Pregnancy ; Contra indication to antiemetics; Chronic usage of antiemetics; and Emergent or complicated surgery.

Risk factors for postoperative nausea and vomiting were collected and patients were randomized by cluster into two arms.

Control: No prophylaxis whatever risk score is. Postoperative nausea and vomiting risk factors were not available for practicians.

Intervention: Preoperative collection of postoperative nausea and vomiting risk factors available for practicians. Prophylaxis if risk score is over 2. Prophylaxis of postoperative nausea and vomiting by betamethasone (4mg) and/or droperidol (0.625mg) immediately after cardiac surgery, depending on risk factors in the intervention arm.

All outcomes are assessed at 48 hours of surgery:

Primary: occurrence of postoperative nausea or vomiting Secondary: number of postoperative nausea and vomiting with visual assessment scale (VAS), and antiemetics used for treatment; postoperative pain (VAS) with number of analgesics used; postoperative discomfort (VAS).

Safety data: side effects and QT corrected intervals. ;

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02744495
Study type	Interventional
Source	Hôpital Privé de Parly II - Le Chesnay
Contact
Status	Completed
Phase	Phase 3
Start date	February 2016
Completion date	December 2016

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT03639012` - Outcomes of Carbohydrate Loading Paediatric Patients Preoperatively for Tonsillectomy and Adenoidectomy	N/A
Not yet recruiting	`NCT01389570` - Postoperative Nausea/Vomiting and Acupressure	Phase 2
Completed	`NCT00830089` - Trial of a Transversus Abdominis Plane (TAP) Block in Laparoscopic Colorectal Surgery	N/A
Terminated	`NCT05112575` - Evaluation of Patient Stress Level Caused by Radiological Investigations in Early Postoperative Phase After Craniotomy
Completed	`NCT04759079` - The Effects of Acupuncture Against Postoperative Nausea and Vomit After Laparoscopic Cholecystectomy	N/A
Active, not recruiting	`NCT03712891` - Evaluation of Providing Coffee to Patients Postoperatively to Decrease Length of Stay in the PACU	N/A
Completed	`NCT01834898` - Safety and Tolerability of Controlled-release Oxycodone on Postoperative Pain in Oncologic Head and Neck Surgery	N/A
Completed	`NCT03631004` - Pre-operative Olanzapine as Prophylactic Antiemetic in Oncologic Patients	Phase 2/Phase 3
Completed	`NCT05618236` - Sugammadex and Neostigmine in Pediatric Patients
Not yet recruiting	`NCT05632224` - Postoperative Nausea and Vomiting in Laparoscopic Abdominal Surgery	Phase 4
Completed	`NCT01020903` - Aprepitant for Post-operative Nausea	N/A
Completed	`NCT00793663` - Depth of Hypnosis and Postoperative Nausea and Vomiting During Xenon Anaesthesia	Phase 4
Completed	`NCT03503292` - Pharmacogenomics and Post-Operative Nausea and Vomiting	Phase 4
Completed	`NCT05841693` - Quality of Recovery in Parturients Consumed Preoperative Carbohydrate Fluid for Elective Cesarean Delivery	Phase 4
Completed	`NCT04742660` - The Effect of Glycyrrhizin on the Occurrence of Postoperative Nausea and Vomiting	N/A
Completed	`NCT03100669` - Implementing a Postoperative MIRP (Minimally Invasive Repair of Pectus) Program Via Tele-monitoring
Terminated	`NCT02765750` - Postoperative Outcomes After Positive Intraoperative Messages	N/A
Terminated	`NCT01798316` - IV Acetaminophen for Postoperative Analgesia	Phase 4
Completed	`NCT03387956` - Intrathecal Atropine to Prevent Postoperative Nausea and Vomiting	N/A
Completed	`NCT04718727` - Olanzapine for the Prevention of Postoperative Nausea and Vomiting	Phase 1/Phase 2

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Prophylaxis of Postoperative Nausea and Vomiting After Cardiac Surgery — PONVACS

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms